Life Sciences & Medicine Active Updated Nov 20, 2026
A gene dimmer switch for drug-resistant epilepsy
Where it stands as of Nov 20, 2026
Three men who had lived with epilepsy for at least a decade saw monthly seizures drop by more than 90 percent in a pilot chemogenetic gene therapy trial, and one stayed seizure-free for a year. The evidence is three patients in an early trial. Whether the effect holds in larger groups and over longer follow-up is not known.
The story so far
-
Nov 20, 2026 Latest
SingularityHub reported that three men with epilepsy for at least a decade saw monthly seizures fall by more than 90 percent in a pilot trial, and one stayed seizure-free for a year. The team delivered a gene into the hippocampal patch where seizures began, and the protein it makes turns that region's activity down when an FDA-approved drug activates it. Dimitri Kullmann of University College London, who was not involved, said it has caused a lot of excitement in the field.
This story moves with the morning letter.
When this question gets a new answer, the page above changes the same morning. Each morning's letter brings the day's progress in science, medicine and beyond. Free, every day.
Free for good. One click to leave.